{
    "Trade/Device Name(s)": [
        "cobas Influenza A/B & RSV nucleic acid test for use on the cobas Liat System",
        "cobas\u00ae Influenza A/B & RSV Nucleic Acid Test for Use on the cobas\u00ae Liat\u00ae System"
    ],
    "Submitter Information": "Roche Molecular Systems, Inc.",
    "510(k) Number": "K213822",
    "Predicate Device Reference 510(k) Number(s)": [
        "K210234"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OCC",
        "OOI"
    ],
    "Summary Letter Date": "December 7, 2021",
    "Summary Letter Received Date": "December 8, 2021",
    "Submission Date": "September 24, 2021",
    "Regulation Number(s)": [
        "21 CFR 866.3980",
        "21 CFR 862.2570"
    ],
    "Regulation Name(s)": [
        "Respiratory Viral Panel Multiplex Nucleic Acid Assay",
        "Real Time Nucleic Acid Amplification System"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Influenza A virus RNA",
        "Influenza B virus RNA",
        "Respiratory syncytial virus (RSV) RNA"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal Swab"
    ],
    "Specimen Container(s)": [
        "cobas\u00ae Influenza A/B & RSV assay tube"
    ],
    "Instrument(s)/Platform(s)": [
        "cobas\u00ae Liat\u00ae Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time RT-PCR",
        "Silica-magnetic bead-based nucleic acid extraction",
        "Multiplex assay"
    ],
    "Methodologies": [
        "RT-PCR",
        "Multiplex nucleic acid testing"
    ],
    "Submission Type(s)": [
        "Assay",
        "Quality Control Kit",
        "Analyzer",
        "Tube",
        "Software",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for cobas Influenza A/B & RSV nucleic acid test on the cobas Liat System for multiplex detection of respiratory viruses using automated RT-PCR.",
    "Indications for Use Summary": "Qualitative detection and discrimination of Influenza A virus, Influenza B virus, and RSV RNA in nasopharyngeal swab specimens from patients with signs and symptoms of respiratory infection, as an aid in differential diagnosis, not intended to detect Influenza C.",
    "fda_folder": "Microbiology"
}